TOI
Oncology Institute Inc
6.20$
+20.9%
vs. previous close
Closing price · As of: Aug 11, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.0% | -4.2% | -2.3% | -12.2% | -0.2% | -3.6% | -5.0% | -2.6% | +2.4% | +0.6% | +2.2% | |
| – | +46.7% | -6.0% | -1.6% | -17.7% | +0.2% | -3.4% | -5.0% | -1.9% | +5.1% | +2.4% | +3.7% | |
| – | -4.7% | +21.6% | +7.7% | +1.0% | +30.1% | +4.8% | -20.0% | -23.8% | -8.7% | +21.4% | -9.8% | |
| – | +123.1% | -5.2% | -20.5% | -29.6% | +2.2% | +4.8% | -20.0% | -23.8% | -8.7% | +21.4% | -9.8% | |
| – | +4.3% | -12.3% | +37.8% | -8.1% | +0.9% | -11.3% | +2.0% | +12.1% | +7.8% | -1.1% | +0.2% | |
| – | +0.0% | +12.4% | -15.5% | -2.0% | -10.7% | -0.7% | +22.6% | +28.3% | +19.6% | -10.6% | +43.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -4.0% | -3.5% | -4.3% | -4.5% | -4.7% | -5.0% | -5.2% | -11.3% | -5.8% | -6.1% | -6.5% | |
| – | +0.9% | +3.9% | +7.2% | -7.9% | +8.8% | +3.3% | -6.0% | +6.2% | +4.2% | +2.5% | +2.3% | |
| – | -3.3% | +7.4% | +31.6% | -23.3% | +33.2% | +11.7% | +14.0% | +8.8% | +1.2% | +8.2% | +11.8% | |
| – | +1.3% | +4.7% | +0.4% | +104.7% | -48.4% | +0.7% | +0.3% | +7.1% | -1.9% | -0.1% | +3.5% | |
| – | +1.6% | +8.2% | +45.6% | -25.1% | +56.0% | -1.0% | +20.4% | +19.3% | +2.0% | +21.1% | +10.4% | |
| – | +1.9% | +1.8% | +1.8% | +1.8% | +1.8% | +1.7% | -20.7% | +1.5% | +1.6% | +1.6% | +1.6% | |
| – | -15.2% | -20.6% | -27.6% | -29.3% | -47.0% | -76.8% | +41.2% | -277.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.9% | +0.0% | +1.0% | +0.7% | +1.0% | +0.2% | +1.9% | +1,108.9% | +4.6% | +4.1% | +0.3% |
Data as of: August 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.